September 07, 2022 08:00 AM Eastern Daylight Time GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company controlling…
Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papilloma virus (HPV) associated tumors, and additional…
The competition nurtures young scientists around the globe QIAGEN-Verogen generously donated a combined instrument and reagents prize package worth up…